The genes for a new enterotoxin were cloned from Escherichia coli SA53. The new toxin was heat labile and activated adenylate cyclase but was not neutralized by antisera against cholera toxin or E. coli heat-labile enterotoxin. Subcloning and minicell experiments indicated that the toxin is composed of two polypeptide subunits that are encoded by two genes. The two toxin subunits exhibited mobilities on polyacrylamide gels that are similar to those of cholera toxin and E. coli heat-labile enterotoxin subunits. A 0.8-kilobase DNA probe for the new enterotoxin failed to hybridize with the cloned structural genes for E. coli heat-labile enterotoxin.
Several diarrheal diseases are caused by enterotoxinproducing bacteria. Escherichia coli strains have been found to produce heat-labile enterotoxin (LT), heat-stable enterotoxin, and Shiga-like toxin (11, 25) . We reported previously that E. coli SA53 produces a new enterotoxin that is not plasmid mediated (9) . Strain SA53 was isolated from the feces of a water buffalo in a rural village in Thailand. The enterotoxin produced by SA53 is not neutralized by hyperimmune antiserum against cholera toxin (CT) or LT produced by E. coli. The new toxin is, however, heat labile and causes activation of adenylate cyclase in Y1 adrenal cells. In addition, a partially purified preparation of LT-like toxin produces a secretory response in rabbit ileal loops (16) . Because of these similarities with the biologic activities of LT, we tentatively named the new enterotoxin LT-like toxin.
Attempts to purify and study the new toxin have been hindered by the small amount of toxin produced by SA53 (10, 16) . In this study, we cloned the toxin genes, increased the amount of toxin produced, identified the toxin subunits, and studied the relatedness of the LT-like toxin genes to those of LT.
MATERIALS AND METHODS
Bacterial strains and plasmids. E. coli SA53 and HE105 are described by Green et al. (9) , and E. coli HE12 is described by Bramucci et al. (3) . The E. coli minicell-producing strain P678-54 is described by Adler et al. (1) . The plasmid pMOB45 (2) , which has a temperature-sensitive defect in replication control resulting in high copy number during growth at 40°C, was obtained from the American Type Culture Collection. Plasmid pHC79 is described by Hohn and Collins (13) , and plasmids pEWD200 and pEWD299 are described by Dallas et al. (5) . Plasmids pBR322 and pACYc184 were used as vectors for subcloning as described by Maniatis et al. (20) . Media . Bacterial strains to be tested for LT-like toxin production were routinely grown in glucose-syncase medium (9), supplemented with 10 jig of lincomycin per ml (30) .
Bacteria were grown in L medium for all other experiments (23) . Antibiotics were used in media at the following concentrations (micrograms per milliliter): ampicillin, 50; tetracycline, 25 ; chloramphenicol, 25 .
Assay for LT-like toxin. The mouse Y1 adrenal cell tissue culture assay for LT-like toxin is described by Green et al. * Corresponding author. (9) . The assay was modified to accommodate the screening of large numbers of potential LT-like toxin clones. Cultures 1 ml in volume were used, and cell pellets were suspended in 0.3-ml samples of RPMI 1640 medium supplemented with 3% fetal calf serum. After the cells were disrupted by sonication for 30 s, the cell debris was pelletted, and either 200-or 100-,u samples of supernatant were applied directly to Y1 cell monolayers in microtiter plates.
Isolation of DNA, restriction of DNA, transformations, and packaging. Plasmid DNA was isolated by the method of Maniatis et al. (20) . Total bacterial cell DNA was isolated as outlined by Silhavy et al. (26) (19) . Approximately 100,000 trichloroacetic acid-precipitable cpm per sample were loaded on the gels for all samples. Autoradiograms were made with Kodak X-Omat AR film.
Purification of toxins. LT-like toxin was purified from E. coli HB101(pCP3837). The purified LT-like toxin caused rounding of Y1 adrenal cells in the assay described above at a dose of approximately 1 pg; the details of purification and characterization of this toxin will be published elsewhere (R. K. Holmes, E. M. Twiddy, and C. L. Pickett, manuscript in preparation). CT and the LT produced by E. coli HE12 were isolated and purified as previously described (14, Preparation of anti-LT-like antiserum. Rabbits were injected intramuscularly with 2 p.g of purified LT-like toxin in Freund complete adjuvant at day 1, 2 ,ug of purified toxin in incomplete Freund adjuvant at 2 weeks and 4 weeks, and finally with 1 ,ug of toxin in incomplete Freund adjuvant at 6 weeks. Immune serum was collected at intervals of 1 week after the final immunization, and pools of serum from each rabbit were prepared and stored at -20°C. Normal serum was obtained from the rabbits before the initial immunization.
Immunoprecipitations. The immunoprecipitation of minicell proteins was carried out essentially as described by Kessler (18) . Labeled minicells equivalent to 106 cpm per sample were used for the immunoprecipitation. The minicells were disrupted by boiling for 5 min in 1% SDS. Rabbit anti-LT-like toxin antiserum or normal antiserum (20 ,ul) was used per sample. Pansorbin (Calbiochem-Behring, La Jolla, Calif.) was used as a source of staphylococcal protein A, and RIPA (10 mM Tris hydrochloride [pH 7.8], 0.5 M NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 0.02% NaN3) was the washing buffer. A total of 15,000 cpm per sample was applied to the gel. After electrophoresis, the gels were dried, and autoradiographs were prepared.
RESULTS
Cloning of toxin genes. DNA was isolated from E. coli HE105, a derivative of E. coli SA53 which lacks one of the two plasmids present in SA53. The DNA was partially digested with Sau3A. Fragments of approximately 30 to 40 kilobase pairs were purified by sucrose gradient centrifugation and ligated to BamHI-cut, alkaline phosphatase-treated DNA of the cosmid vector pHC79. After the ligated DNA was packaged into lambda phage particles and transduced into E. coli HB101, ampicillin-resistant transductants were selected.
Six toxin-producing transductants were identified among 350 transductants screened in the cultured mouse Y1 adrenal cell assay. All six transductants contained hybrid plasmids with DNA inserts ranging from 35 to 45 kb. Sonic extracts from these transductants contained LT-like toxin with specific activities that were 20-to 30-fold higher than that of extracts from wild-type E. coli SA53. After these six plasmids were purified and digested with EcoRI or HindIll, common fragments were demonstrated by agarose gel electrophoresis. DNA from one of the six clones was cut with EcoRI, subcloned into the vector pMOB45, and transformed into E. coli HB101. An enterotoxin-producing subclone with an insert of about 4 kb of DNA was isolated, and the hybrid plasmid was named pCP3837. E. coli HB101(pCP3837) grown at 40°C produced 500 to 600 times more cellassociated toxin than SA53. The 4.0-kb insert in pCP3837 consisted of a 3.0-kb EcoRI fragment and at least two smaller EcoRI fragments of less than 0.5 kb.
The 3.0-kb EcoRI fragment from pCP3837 was subcloned into pBR322 to produce the hybrid plasmid pCP3727 and into pACYC184 to produce the hybrid plasmid pCP3706. In addition, smaller fragments derived from the 3.0-kb EcoRI insert of pCP3727 were subcloned into appropriate restriction sites in pBR322 and characterized (Fig. 1) . The genes for LT-like toxin were located within the 1.7-kb insert in plasmid pCP2780.
Minicell experiments. The polypeptides encoded by pCP3727 and several other subclones were analyzed in minicell experiments (Fig. 2) . The minicell results showed that two specific polypeptides (28 and 11.8 kilodaltons) are made by all subclones which encode biologically active LT-like toxin. The 11.8-kilodalton protein was absent in minicells containing PCP2725 (Fig. 2, lane E) , and the 28-kilodalton protein was absent in minicells containing pCP2701 (Fig. 2, lane F) (Fig. 3) . The anti-LT-like antiserum which immunoprecipitated the LT-like toxin from minicells also neutralized the toxin produced by E. ccli HB101(pCP3837) orE. ccli SA53 but failed to neutralize either purified LT or CT in the Yl adrenal cell assay.
Relatedness of LT-like toxin to LT. A nick-translated 0.8-kb Hindlll-Pstl fragment from pCP2725 was used in hybridization experiments. Minicell and subcloning experiments ( Fig. 1 and 2 ) indicated that this DNA fragment contained toxin-coding sequences. Control experiments showed that this fragment hybridized well to fragments known to encode LT-like toxin (Fig. 4A, lanes D, E, and F) but did not hybridize to purified DNA from vector pBR322 (Fig. 4A, lane A) or to total DNA isolated from E. ccli K-12 or several other strains of E. ccli that produced no detectable LT-like toxin (data not shown). The 0.8-kb HindIbi-Pstl probe for LT-like toxin genes did not hybridize to purified pEWD299, a hybrid plasmid containing the cloned structural genes for LT, at conditions that would allow up to 45% base-pair mismatch (Fig. 4A, lanes B and C) . In addition, the 1.2-kb HincIl fragment from plasmid pEWD200 encoding the A subunit of LT (24) did not hybridize to pCP3727 under conditions that should have allowed approximately 20% base-pair mismatch (Fig. 4B, lane A) .
DISCUSSION
In the studies reported here we cloned and characterized the structural genes for the LT-like toxin of E. coli. Minicell experiments indicated that the LT-like toxin consists of two polypeptides which we have called A and B owing to their similarity in mobility on SDS-polyacrylamide with the A and B polypeptides of LT and CT. Subcloning demonstrated that the A and B subunit genes are contiguous and are contained in the 1.7-kb DNA insert of plasmid pCP2780. About 1.2 kb of this DNA would be required to code for the A and B polypeptides. Both subunits of LT-like toxin are required for full biologic activity in the Y1 adrenal cell assay, because E. coli strains containing clones that code for only the A or the B subunit are reduced in toxicity by at least 1,000-fold.
Additional similarities among LT-like toxin, LT, and CT include their heat lability, their enterotoxicity, their ability to cause characteristic morphologic changes in Y1 adrenal cells or Chinese hamster ovary cells, and their ability to activate adenylate cyclase in susceptible eucaryotic target cells (9, 10, 16) . Recent experiments also demonstrated that purified LT-like toxin has NAD-dependent ADP ribosyl-transferase activity and ADP ribosylates the G, regulatory subunit of adenylate cyclase in human fibroblasts (P. P. Chang, J. Moss, E. M. Twiddy, and R. K. Holmes, manuscript in preparation). In biologic activity, therefore, LT-like toxin closely resembles LT and CT.
Despite these many similarities, however, LT-like toxin also differs significantly from CT and LT. Antiserum against purified LT or CT fails to neutralize LT-like toxin (9) , and antiserum against the purified LT-like toxin encoded by cloned LT-like toxin genes fails to neutralize LT or CT. Furthermore, DNA probes for the A and B polypeptide subunit genes of LT fail to hybridize with the genes for LT-like toxin in E. coli SA53 and strains derived from it (9), and the results reported here demonstrate that the cloned genes for LT-like toxin do not hybridize with the cloned genes for LT in plasmid EDW299 under conditions that should allow for approximately 45% mismatch in their nucleotide sequences.
These observations demonstrate that LT-like toxin is similar to LT and CT in terms of its polypeptide subunits, enzymatic activity, and mechanism of action but differs significantly from them in antigenicity and, presumably, in primary structure. Determination of the nucleotide sequence of the cloned structural genes for LT-like toxin will be required to provide definitive data concerning the extent of their homology with structural genes for LT or CT. Previous studies demonstrated that LT and CT belong to the cholera-E. coli family of LTs (8, 12) . On the basis of the observations cited above we propose that the definition of the cholera-E. coli enterotoxin family should be broadened to include LT-like toxin and that two different serogroups should be recognized. CT is the prototype for LTs, and we propose to designate as serogroup I those enterotoxins that can be neutralized by antiserum against CT. The LTp and LTh antigenic variants of LT (15, 17) will both be included in serogroup I and should be designated LTp-I and LTh-I. LT-like toxin will be the prototype for serogroup II enterotoxins and should be renamed LT-II. Additional serogroups can be defined if other LTs are discovered that activate adenylate cyclase by a similar mechanism but cannot be neutralized by antiserum against CT or LT-II. This proposed system of nomenclature is consistent with that used for other bacterial protein toxins with multiple serotypes, such as botulinum toxin (27) , staphylococcal enterotoxin (7), or streptococcal erythrogenic toxin (28, 29 We are currently testing the HindIII-PstI fragment from plasmid pCP2725 further to determine its specificity as a probe for identifying the structural genes for LT-II in E. coli. A specific DNA probe for LT-II should be helpful in establishing the prevalence of this toxin or its structural genes or both among natural isolates of E. coli. Such studies will also provide a starting point for defining the role of LT-II as a potential virulence factor in gastrointestinal or other infections caused by E. coli in humans or in economically important animals.
